Average Co-Inventor Count = 5.82
ph-index = 7
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Janssen Pharmaceutica Nv (19 from 2,076 patents)
2. Ortho-mcneil Pharmaceutical Corp. (7 from 363 patents)
3. Epigen Biosciences, Inc. (6 from 6 patents)
4. Other (2 from 832,680 patents)
5. Janssen Pharmaceutica (1 from 32 patents)
6. Ortho-mcneil Pharmaceuticlas, Inc. (1 from 1 patent)
7. Janssen Pharmaceuticals, Inc. (159 patents)
36 patents:
1. 12378254 - Disubstituted octahydropyrrolo[3,4-c]pyrroles as orexin receptor modulators
2. 12234224 - Pyrimidine and pyridine amine compounds and usage thereof in disease treatment
3. 11866421 - Pyrimidine and pyridine amine compounds and usage thereof in disease treatment
4. 11667644 - Disubstituted octahydropyrrolo[3,4-c]pyrroles as orexin receptor modulators
5. 11427552 - Heterocyclic compounds useful in the treatment of disease
6. RE48841 - Disubstituted octahydropyrrolo[3,4-c]pyrroles as orexin receptor modulators
7. 11059828 - Disubstituted octahydropyrrolo[3,4-C]pyrroles as orexin receptor modulators
8. 10570103 - Heterocyclic compounds useful in the treatment of disease
9. 10526298 - Heterocyclic compounds useful in the treatment of disease
10. 10000459 - Heterocyclic compounds useful in the treatment of disease
11. 9981909 - Serotonin receptor modulators
12. 9079911 - Disubstituted octahydropyrrolo[3,4-c]pyrroles as orexin receptor modulators
13. 9062044 - Disubstituted octahydropyrrolo[3,4-c]pyrroles as orexin receptor modulators
14. 8680275 - Fused heterocyclic compounds as orexin receptor modulators
15. 8653263 - Disubstituted octahydropyrrolo[3,4-c]pyrroles as orexin receptor modulators